SEROLOGIC RESPONSE TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON IMMUNOSUPPRESSIVE THERAPY: ASSOCIATION TO DISEASE TYPE AND SERUM DRUG LEVELS

Kristin Kaasen Jørgensen  ¹     Marte Lie Høivik  ²     Adity Chopra  ²     Jurate Saltyte Benth  ²     Petr Ricanek  ²     Bjorn Moum  ³     Ingrid Jyssum  ⁴     Nils Bolstad  ⁴     David J. Warren  ⁴     John Torgils Vaage  ⁴     Ludvig Andre Munthe  ⁴     Knut E.A. Lundin  ⁴     Karoline Anisdahl  ⁴     Silje W. Syversen  ⁴     Guro Lovik Goll  ⁴     Fridtjof Lund-Johansen  ⁴     Asle W. Medhus  ⁴     Jørgen Jahnsen  ^4    
1 Akershus University Hospital, Lørenskog, Norway
² Oslo University Hospital, Oslo, Norway
³ University of Oslo, Oslo, Norway
⁴ Diakonhjemmet Hospital, Oslo, Norway

Topic
IBD, Neurogastroenterology & Motility, Nurses, Primary Care

Session
COVID-19 complications in the lower GI tract

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)